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background:  MicroRNAs (miR) are actively involved in the physiological function of stem cells. Stem cell factor (SCF) is one of the 
stimulating cytokine, and this study was designed to determine the critical regulator of SCF.
methods:  By using database, miR-34c was chosen to study the effect on SCF in bone marrow mesenchymal stem cells (BMCs). In vitro 
angiogenesis was assessed by Matrigel assay. Myocardial infarction (MI) was induced by ligation of coronary artery in nude mouse, and 
BMCs were injected into the border zone 7 days later, and histological studied were performed two weeks later.
Results:  miR-34c significantly impaired tube formation of BMC, and SCF was confirmed as a target of miR-34c by 3’-UTR promoter 
analysis. In miR-34c transfected BMCs, the levels of mRNA and protein of SCF were decreased. Additionally, SCF knockdown by siRNA 
resulted in the blockade of angiogenesis. Unexpectedly, Kruppel-like factor 4 (KLF4) was induced by both SCF knockdown and miR-34c 
overexpression in BMCs. In KLF4-overexpressed BMCs, tube formation was completely blocked, while the level of SCF was not changed. 
When KLF4 was knockdowned by siRNA, miR-34c failed to inhibit tube formation in BMCs. From these results, miR-34c was suggested to 
target SCF to inhibit angiogenesis, and KLF4 might be a downstream effector of SCF. To determine the therapeutic potential, BMCs were 
transfected with miR-control or miR-34c and injected into the myocardium. Cardiac fibrosis was 18.24 ± 4.70% in miR-34c-BMC group 
and 10.01 ± 0.18% in miR-con-BMC group (p<0.05). Cardiac function and vessel density were decreased in the miR-34c-BMC group as 
compared with the miR-con-BMC group. Collectively, miR-34c negatively regulated the angiogenic potential through suppression of SCF, 
and subsequent induction of KLF4 in BMCs.
conclusion:  Our results show that the angiogenic activity of BMCs is finely regulated by miR-34c-SCF-KLF4 axis which is a potent 
translational target for optimizing therapeutic activity of autologous BMCs for cardiac repair.
